サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1515384

軟部肉腫市場：治療タイプ別、投与経路別、流通チャネル別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Soft Tissue Sarcoma Market, By Treatment Type, By Route of Administration, By Distribution Channel, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 400 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
軟部肉腫市場：治療タイプ別、投与経路別、流通チャネル別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月24日
発行: AnalystView Market Insights
ページ情報: 英文 400 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

軟部肉腫市場規模は2023年に28億7,632万米ドルとなり、2024年から2032年にかけてCAGR 5.4％で拡大

軟部肉腫市場-市場力学

軟部肉腫をより深く理解するための継続的な調査が市場需要を促進する

軟部肉腫治療市場の拡大は、主に細胞分裂と増殖を制御する特定の遺伝子の異常な活性によって推進されます。がん遺伝子と呼ばれるこれらの遺伝子は、軟部肉腫細胞内で変異や活性化を起こし、その結果、抑制の効かない成長や急速な増殖を引き起こします。さらに、軟部肉腫細胞は、細胞の増殖と分裂を促進するシグナル伝達分子である増殖因子を大量に産生することがあります。軟部肉腫はまれなタイプのがんと考えられているが、それにもかかわらず、生命を脅かす重篤な疾患であり、過小評価されるべきではないです。軟部肉腫は他の種類のがんに比べて有病率が低いにもかかわらず、依然として世界中で相当数の人々が罹患しています。さらに、軟部肉腫の原因が完全には解明されていないという事実は、この疾患をよりよく理解し、より効果的な治療戦略を開発するための継続的な研究の必要性を強調しています。

軟部肉腫市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）にCAGR約5.4%で年間成長すると推定されます。

治療タイプ別では、化学療法が2023年に最大の市場シェアを示すと予測されています。

エンドユーザーセグメンテーションでは、2023年に病院が主要なタイプでした。

地域別では、北米が2023年に収益でリードしました。

軟部肉腫市場-セグメンテーション分析：

世界の軟部肉腫市場は、治療タイプ、投与経路、流通チャネル、エンドユーザー、地域に基づいてセグメント化されます。

市場は治療タイプ別に5つに分類される：すなわち、標的療法、化学療法、血管新生阻害薬、放射線療法、その他です。化学療法は、その長年にわたる有効性と様々な肉腫サブタイプへの幅広い適用により、現在軟部肉腫市場の治療状況を支配しています。標的治療や他の先進治療が出現しているにもかかわらず、化学療法は、急速に分裂するがん細胞を全身的に標的とする能力により、局所および転移性疾患の両方に適しているため、依然として要となっています。化学療法レジメンの多用途性により、手術や放射線などの他の治療との併用が可能となり、全体的な治療効果が高まる。さらに、化学療法はプロトコールが確立されており、新しい治療法に比べて比較的低コストであることも、市場での優位性に寄与しています。

市場はエンドユーザーによって4つのカテゴリーに分けられる：病院、在宅医療、専門センター、その他です。軟部肉腫市場において病院が主要なエンドユーザーとなっているのは、その包括的なリソースと複雑ながん治療を管理する能力によるところが大きいです。病院は集学的治療を提供しており、手術、化学療法、放射線療法、支持療法を組み合わせた治療を必要とする肉腫患者にとって極めて重要です。専門の腫瘍専門医の存在、高度な診断ツール、副作用や合併症の管理能力により、病院は初期治療と継続的治療の両方に適した環境となります。さらに、病院は臨床試験や先端研究の拠点となることが多く、患者は最先端の治療やより高水準の治療を受けることができます。

軟部肉腫市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに区分されます。北米市場は、予測期間中に最大の市場シェアを記録し、2023年には主要な収益地位を築くと予測されています。米国がん協会によると、2016年には推定12,390人が軟部肉腫および関連がんと診断されました。軟部肉腫の罹患率の高さ、この疾患に対する認識の高まり、ヘルスケアへの注目の高まり、医療インフラの確立などが、市場収益の成長を促す主な要因です。

軟部肉腫市場-競合情勢：

競争の激しい軟部肉腫（STS）市場では、主要企業が戦略的提携を結んで製品ラインナップを充実させています。他の製薬企業、研究機関、学術センターと手を組むことで、企業はそれぞれの専門知識、リソース、技術を結集してイノベーションを推進し、新たな治療法や診断ツールを開発することができます。このような提携はデータや知識の共有も促進し、研究開発のペースを加速させる。さらに、パートナーシップは企業の市場リーチを拡大し、新たな地域や患者集団へのアクセスを可能にします。効率的な治療法に対する需要は、一般的な腫瘍の発生率の増加とともに高まっています。その結果、多国籍企業は革新的な医薬品を生み出すための研究開発に収益のかなりの部分を投資しています。先進的な薬物送達システムに関連するいくつかの品目は、FDAの承認を待っています。胆嚢腫瘍を治療する先進的な医薬品に対する需要の高まりは、市場の拡大をさらに促進すると予想されます。

目次

第1章 軟部肉腫市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 軟部肉腫の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 軟部肉腫産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 軟部肉腫市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 軟部肉腫市場情勢

  • 軟部肉腫市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 軟部肉腫市場：治療タイプ別

  • 概要
    • セグメントシェア分析
    • 標的療法
    • 化学療法
    • 抗血管新生薬
    • 放射線治療
    • その他

第8章 軟部肉腫市場：投与経路別

  • 概要
    • セグメントシェア分析
    • 経口
    • 非経口
    • その他

第9章 軟部肉腫市場：流通チャネル別

  • 概要
    • セグメントシェア分析
    • 病院薬局
    • オンライン薬局
    • 小売薬局

第10章 軟部肉腫市場：エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院
    • 在宅ケア
    • 専門センター
    • その他

第11章 軟部肉腫市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：軟部肉腫業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Genentech USA
    • Pfizer, Inc.
    • Eli Lilly and Company
    • Bristol-Myers Squibb
    • Hoffmann-La Roche Ltd.
    • Johnson &Johnson, Inc.
    • GlaxoSmithKline
    • Teva Pharmaceuticals
    • Celgene Corporation
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Soft Tissue Sarcoma Market: Treatment Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Soft Tissue Sarcoma Market, by Treatment Type 2019-2032 (USD Million)
  • TABLE Soft Tissue Sarcoma Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Soft Tissue Sarcoma Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Soft Tissue Sarcoma Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Soft Tissue Sarcoma Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Soft Tissue Sarcoma Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Soft Tissue Sarcoma Market, by End User 2019-2032 (USD Million)
  • TABLE Soft Tissue Sarcoma Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Soft Tissue Sarcoma Market, by Region 2019-2032 (USD Million)
  • TABLE North America Soft Tissue Sarcoma Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Soft Tissue Sarcoma Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE North America Soft Tissue Sarcoma Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Soft Tissue Sarcoma Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE North America Soft Tissue Sarcoma Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Soft Tissue Sarcoma Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Soft Tissue Sarcoma Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Europe Soft Tissue Sarcoma Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Soft Tissue Sarcoma Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Soft Tissue Sarcoma Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Soft Tissue Sarcoma Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Soft Tissue Sarcoma Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Soft Tissue Sarcoma Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Soft Tissue Sarcoma Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Soft Tissue Sarcoma Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Soft Tissue Sarcoma Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Soft Tissue Sarcoma Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Latin America Soft Tissue Sarcoma Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Soft Tissue Sarcoma Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Soft Tissue Sarcoma Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Soft Tissue Sarcoma Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Soft Tissue Sarcoma Market, by Treatment Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Soft Tissue Sarcoma Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Soft Tissue Sarcoma Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Soft Tissue Sarcoma Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Soft Tissue Sarcoma Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Treatment Type segment market share analysis, 2023 & 2032
  • FIGURE Treatment Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2023 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2023 & 2032
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Soft Tissue Sarcoma Market share and leading players, 2023
  • FIGURE Europe Soft Tissue Sarcoma Market share and leading players, 2023
  • FIGURE Asia Pacific Soft Tissue Sarcoma Market share and leading players, 2023
  • FIGURE Latin America Soft Tissue Sarcoma Market share and leading players, 2023
  • FIGURE Middle East and Africa Soft Tissue Sarcoma Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Soft Tissue Sarcoma Market share analysis by country, 2023
  • FIGURE Germany Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Soft Tissue Sarcoma Market share analysis by country, 2023
  • FIGURE India Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Soft Tissue Sarcoma Market share analysis by country, 2023
  • FIGURE Brazil Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Soft Tissue Sarcoma Market share analysis by country, 2023
  • FIGURE Saudi Arabia Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Soft Tissue Sarcoma Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3116

REPORT HIGHLIGHT

Soft Tissue Sarcoma Market size was valued at USD 2,876.32 Million in 2023, expanding at a CAGR of 5.4% from 2024 to 2032.

Soft tissue sarcoma is a form of cancer originating in soft tissues like muscles, tendons, fat, lymph and blood vessels, and nerves. While they can develop in any part of the body, they are frequently located in the arms, legs, chest, and abdomen. With around 50 distinct types, identifying soft tissue sarcomas can pose a challenge. While some types predominantly affect adults, others are more common in children. The most common form of treatment is surgical removal, although radiation therapy and chemotherapy may also be recommended depending on the tumor's size, nature, location, and aggressiveness.

Soft Tissue Sarcoma Market- Market Dynamics

Need for continued research to better comprehend this disease to propel market demand

The expansion of the soft tissue sarcoma treatment market is chiefly propelled by the aberrant activity of specific genes governing cell division and growth. These genes, termed oncogenes, may undergo mutations or activation within soft tissue sarcoma cells, resulting in unchecked growth and rapid proliferation. Additionally, soft tissue sarcoma cells may produce high levels of growth factors, which are signaling molecules that promote cell growth and division. Although soft tissue sarcoma is considered a rare type of cancer, it is nonetheless a serious and life-threatening disease that should not be underestimated. Despite its lower prevalence compared to other types of cancer, soft tissue sarcoma still affects a significant number of people worldwide. Moreover, the fact that the causes of soft tissue sarcoma are not fully understood underscores the need for continued research to better comprehend this disease and develop more effective treatment strategies.

Soft Tissue Sarcoma Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.4% over the forecast period (2024-2032)

Based on Treatment Type segmentation, Chemotherapy was predicted to show maximum market share in the year 2023

Based on End User segmentation, Hospitals were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Soft Tissue Sarcoma Market- Segmentation Analysis:

The Global Soft Tissue Sarcoma Market is segmented based on Treatment Type, Route of Administration, Distribution Channel, End User, and Region.

The market is divided into five categories based on Treatment Type: Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, and Others. Chemotherapy currently dominates the treatment landscape in the soft tissue sarcoma market due to its longstanding efficacy and broad application across various sarcoma subtypes. Despite the emergence of targeted therapies and other advanced treatments, chemotherapy remains a cornerstone because of its ability to target rapidly dividing cancer cells systemically, making it suitable for both localized and metastatic disease. The versatility of chemotherapy regimens allows for their use in combination with other treatments such as surgery and radiation, thereby enhancing overall treatment effectiveness. Additionally, chemotherapy's established protocols and relatively lower costs compared to newer therapies contribute to its dominance in the market.

The market is divided into four categories based on End Users: Hospitals, Homecare, Speciality Centres, and Others. Hospitals serve as the primary end-users in the soft tissue sarcoma market, largely due to their comprehensive resources and capabilities in managing complex cancer treatments. Hospitals offer multidisciplinary care, which is crucial for sarcoma patients who often require a combination of surgery, chemotherapy, radiation, and supportive care. The presence of specialized oncologists, advanced diagnostic tools, and the ability to manage side effects and complications make hospitals the preferred setting for both initial and ongoing treatment. Furthermore, hospitals are often centers for clinical trials and advanced research, offering patients access to cutting-edge therapies and a higher standard of care.

Soft Tissue Sarcoma Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The North American market is anticipated to register the largest market share during the forecast period, building on its leading revenue position in 2023. According to the American Cancer Society, an estimated 12,390 individuals were diagnosed with soft tissue sarcoma and associated cancers in 2016. Key factors driving market revenue growth include the high incidence rate of soft tissue sarcomas, increasing awareness of this condition, a growing focus on healthcare, and a well-established healthcare infrastructure.

Soft Tissue Sarcoma Market- Competitive Landscape:

In the competitive soft tissue sarcoma (STS) market, major players engage in strategic partnerships to enhance their offerings. By joining forces with other pharmaceutical firms, research institutions, or academic centers, companies can leverage their combined expertise, resources, and technologies to drive innovation and develop new treatments or diagnostic tools. These collaborations may also facilitate the sharing of data and knowledge, accelerating the pace of research and development. Additionally, partnerships can expand companies' market reach and enable them to access new geographic regions or patient populations. The demand for efficient therapies has grown alongside an increased incidence rate of tumors in general. Consequently, multinational corporations are investing a substantial portion of their earnings into research and development to create innovative pharmaceuticals. Several items connected to advanced medication delivery systems are awaiting FDA approval. It is anticipated that the rising demand for advanced drugs to treat gallbladder tumors will further drive market expansion.

Recent Developments:

In December 2020, the FDA granted an orphan drug designation to Moeculin Biotech's annamycin for soft tissue sarcoma.

In October 2020, Rafael Pharmaceuticals announced receiving an FDA grant of an Orphan Drug designation to CPI-613 (devimistat) indicated to treat soft tissue sarcoma. These designations underscore the importance of developing novel treatments for this challenging disease and highlight the ongoing efforts within the pharmaceutical industry to address unmet medical needs in soft tissue sarcoma.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SOFT TISSUE SARCOMA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Genentech USA

Pfizer, Inc.

Eli Lilly and Company

Bristol-Myers Squibb

Hoffmann-La Roche Ltd.

Johnson & Johnson, Inc.

GlaxoSmithKline

Teva Pharmaceuticals

Celgene Corporation

Others

GLOBAL SOFT TISSUE SARCOMA MARKET, BY TREATMENT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Targeted Therapy
  • Chemotherapy
  • Anti-Angiogenesis Drugs
  • Radiation Therapy
  • Others

GLOBAL SOFT TISSUE SARCOMA MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Parenteral
  • Others

GLOBAL SOFT TISSUE SARCOMA MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

GLOBAL SOFT TISSUE SARCOMA MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

GLOBAL SOFT TISSUE SARCOMA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Soft Tissue Sarcoma Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Soft Tissue Sarcoma Market Snippet by Treatment Type
    • 2.1.2. Soft Tissue Sarcoma Market Snippet by Route of Administration
    • 2.1.3. Soft Tissue Sarcoma Market Snippet by Distribution Channel
    • 2.1.4. Soft Tissue Sarcoma Market Snippet by End User
    • 2.1.5. Soft Tissue Sarcoma Market Snippet by Country
    • 2.1.6. Soft Tissue Sarcoma Market Snippet by Region
  • 2.2. Competitive Insights

3. Soft Tissue Sarcoma Key Market Trends

  • 3.1. Soft Tissue Sarcoma Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Soft Tissue Sarcoma Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Soft Tissue Sarcoma Market Opportunities
  • 3.4. Soft Tissue Sarcoma Market Future Trends

4. Soft Tissue Sarcoma Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Soft Tissue Sarcoma Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Soft Tissue Sarcoma Market Landscape

  • 6.1. Soft Tissue Sarcoma Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Soft Tissue Sarcoma Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 7.1.2. Targeted Therapy
    • 7.1.3. Chemotherapy
    • 7.1.4. Anti-Angiogenesis Drugs
    • 7.1.5. Radiation Therapy
    • 7.1.6. Others

8. Soft Tissue Sarcoma Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Parenteral
    • 8.1.4. Others

9. Soft Tissue Sarcoma Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Online Pharmacy
    • 9.1.4. Retail Pharmacy

10. Soft Tissue Sarcoma Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Homecare
    • 10.1.4. Speciality Centres
    • 10.1.5. Others

11. Soft Tissue Sarcoma Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Soft Tissue Sarcoma Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Soft Tissue Sarcoma Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Soft Tissue Sarcoma Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Soft Tissue Sarcoma Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Soft Tissue Sarcoma Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Soft Tissue Sarcoma Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Genentech USA
    • 12.2.2. Pfizer, Inc.
    • 12.2.3. Eli Lilly and Company
    • 12.2.4. Bristol-Myers Squibb
    • 12.2.5. Hoffmann-La Roche Ltd.
    • 12.2.6. Johnson & Johnson, Inc.
    • 12.2.7. GlaxoSmithKline
    • 12.2.8. Teva Pharmaceuticals
    • 12.2.9. Celgene Corporation
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us